Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-04

Clinical Trial Update: Methotrexate Alone Versus Combination of Methotrexate and Subcutaneous Fludarabine for Severe Rheumatoid Arthritis: Safety, Tolerance and Efficacy [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing methotrexate alone versus methotrexate plus subcutaneous fludarabine in severe rheumatoid arthritis to assess safety, toler…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fludarabine (Fludarabine)
  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Arthritis, Rheumatoid, Synovitis | Phase 2 | Status: COMPLETED